Incidental Mutation 'F5493:Frrs1l'
ID 566
Institutional Source Beutler Lab
Gene Symbol Frrs1l
Ensembl Gene ENSMUSG00000045589
Gene Name ferric-chelate reductase 1 like
Synonyms 6430704M03Rik
Accession Numbers
Essential gene? Possibly non essential (E-score: 0.425) question?
Stock # F5493 (G1)
Quality Score
Status Validated
Chromosome 4
Chromosomal Location 56960136-56990391 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) T to C at 56968293 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Methionine to Valine at position 160 (M160V)
Ref Sequence ENSEMBL: ENSMUSP00000052507 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000053681] [ENSMUST00000128276]
AlphaFold B1AXV0
Predicted Effect probably benign
Transcript: ENSMUST00000053681
AA Change: M160V

PolyPhen 2 Score 0.130 (Sensitivity: 0.93; Specificity: 0.86)
SMART Domains Protein: ENSMUSP00000052507
Gene: ENSMUSG00000045589
AA Change: M160V

DomainStartEndE-ValueType
signal peptide 1 28 N/A INTRINSIC
DoH 143 232 1.96e-10 SMART
transmembrane domain 267 289 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000128276
Meta Mutation Damage Score 0.2123 question?
Coding Region Coverage
  • 1x: 76.6%
  • 3x: 51.4%
Het Detection Efficiency 27.8%
Validation Efficiency 67% (74/111)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a component of the outer-core of an alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor protein in the brain. The encoded protein is thought to interact with inner-core components of the receptor, and play a role in the modulation of glutamate signaling. Mutations in this gene are associated with early infantile epileptic encephalopathy 37. [provided by RefSeq, Jul 2016]
Allele List at MGI

All alleles(8) : Gene trapped(8)

Other mutations in this stock
Total: 10 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Cars1 T A 7: 143,123,608 (GRCm39) T448S probably damaging Het
Cdca2 T A 14: 67,915,141 (GRCm39) N706I probably damaging Het
Fat1 A G 8: 45,478,517 (GRCm39) E2521G probably damaging Het
Fmo2 C A 1: 162,708,101 (GRCm39) V345L probably benign Het
Nckap5 A T 1: 125,953,564 (GRCm39) M996K probably benign Het
Nlrp4d A T 7: 10,115,011 (GRCm39) D568E possibly damaging Het
Pex1 T G 5: 3,685,912 (GRCm39) probably null Het
Ptprd A G 4: 76,002,645 (GRCm39) L17P probably damaging Het
Tnfsf13b T A 8: 10,056,916 (GRCm39) V25E probably damaging Het
Zfp386 T C 12: 116,023,922 (GRCm39) Y512H probably damaging Het
Other mutations in Frrs1l
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00973:Frrs1l APN 4 56,972,369 (GRCm39) missense probably damaging 1.00
IGL02248:Frrs1l APN 4 56,968,272 (GRCm39) missense probably damaging 1.00
IGL03353:Frrs1l APN 4 56,968,121 (GRCm39) missense probably damaging 1.00
PIT4531001:Frrs1l UTSW 4 56,990,144 (GRCm39) missense unknown
R3002:Frrs1l UTSW 4 56,990,139 (GRCm39) unclassified probably benign
R7199:Frrs1l UTSW 4 56,972,282 (GRCm39) missense probably damaging 1.00
R7230:Frrs1l UTSW 4 56,972,372 (GRCm39) missense probably damaging 1.00
R7312:Frrs1l UTSW 4 56,968,230 (GRCm39) missense probably benign 0.32
R9673:Frrs1l UTSW 4 56,990,191 (GRCm39) missense
Nature of Mutation

DNA sequencing using the SOLiD technique identified an A to G transition at position 598 of the 6430704M03Riktranscript in exon 4 of 5 total exons.  Multiple transcripts of the 6430704M03Rikgene are displayed on Ensembl and Vega. The mutated nucleotide causes a methionine to valine substitution at amino acid 160 of the encoded protein. The mutation has been confirmed by DNA sequencing using the Sanger method (see related file).

Protein Function and Prediction

The 6430704M03Rik gene is predicted to encode a 293 amino acid protein. SMART analysis indicates a signal peptide at amino acids 1-28 and a DoH or DOMON domain at amino acids 118-261. This predominantly beta-sheet domain is typically found in as a regulatory N-terminal domain in dopamine beta-monooxygenase and and in several other secreted and transmembrane proteins. A C-terminal transmembrane domain is located at residues 267-289.

The M160V change is located in the DoH domain, and is predicted to be possibly damaging by the PolyPhen program.

Posted On 2010-11-29